Changes in metabolic toxicity after switching from stavudine/didanosine to tenofovir/lamivudine--a Staccato trial substudy.

Changes in metabolic toxicity after switching from stavudine/didanosine to tenofovir/lamivudine--a Staccato trial substudy.

Item
http://www.wikidata.org/entity/Q34761540
HIV/AIDS and lipodystrophy: implications for clinical management in resource-limited settingsPredictors of limb fat gain in HIV positive patients following a change to tenofovir-emtricitabine or abacavir-lamivudineA pilot study to determine the impact on dyslipidemia of adding tenofovir to stable background antiretroviral therapy: ACTG 5206.Efficacy and safety of tenofovir disoproxil fumarate in patients with chronic hepatitis B.Lipid Metabolism and Cardiovascular Risk in HIV-1 Infection and HAART: Present and Future Problems.HIV and HAART-Associated DyslipidemiaHIV lipodystrophy in participants randomised to lopinavir/ritonavir (LPV/r) +2-3 nucleoside/nucleotide reverse transcriptase inhibitors (N(t)RTI) or LPV/r + raltegravir as second-line antiretroviral therapy.Mitochondrial function, inflammation, fat and bone in HIV lipoatrophy: randomized study of uridine supplementation or switch to tenofovir.Mitochondrial toxicities of nucleoside analogue reverse transcriptase inhibitors in AIDS cases.Diagnosis and treatment of mitochondrial myopathiesFrom old to new nucleoside reverse transcriptase inhibitors: changes in body fat composition, metabolic parameters and mitochondrial toxicity after the switch from thymidine analogs to tenofovir or abacavir.Ophthalmoplegia and ptosis: mitochondrial toxicity in patients receiving HIV therapyThe lipid-lowering effect of tenofovir/emtricitabine: a randomized, crossover, double-blind, placebo-controlled trial.Randomized, crossover, double-blind, placebo-controlled trial to assess the lipid lowering effect of co-formulated TDF/FTC.
P2860

Changes in metabolic toxicity after switching from stavudine/didanosine to tenofovir/lamivudine--a Staccato trial substudy.

Item
http://www.wikidata.org/entity/Q34761540
description
2008 nî lūn-bûn
@nan
2008 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի մարտին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Changes in metabolic toxicity ...... ne--a Staccato trial substudy.
@ast
Changes in metabolic toxicity ...... ne--a Staccato trial substudy.
@en
Changes in metabolic toxicity ...... ne--a Staccato trial substudy.
@nl
type
label
Changes in metabolic toxicity ...... ne--a Staccato trial substudy.
@ast
Changes in metabolic toxicity ...... ne--a Staccato trial substudy.
@en
Changes in metabolic toxicity ...... ne--a Staccato trial substudy.
@nl
prefLabel
Changes in metabolic toxicity ...... ne--a Staccato trial substudy.
@ast
Changes in metabolic toxicity ...... ne--a Staccato trial substudy.
@en
Changes in metabolic toxicity ...... ne--a Staccato trial substudy.
@nl
P1433
P1476
P2093
P304
P31
P356
P407
P433
P478
P50
P577
P5875
P698
P356
P1433
P1476
Changes in metabolic toxicity ...... ne--a Staccato trial substudy.
@en
P2093
P304
P31
P356
P407
P433
P478
P50
P577
P5875
P698